![]() |
||||||
![]() |
||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
||||||
![]() |
![]() |
![]()
|
![]() |
![]() |
CollaboratorsCoordinating centresThe PHI is co-ordinated by the Health Analysis and Measurement Group (HAMG) of Statistics Canada and the Policy Research Unit (PRU) of the Public Health Agency of Canada. The coordinating centres oversee the day-to-day activities of the PHI through four working groups: Health State Preferences Working Group, Data Management Working Group, Microsimulation Working Group, and Dissemination Working Group. The Health Analysis and Measurement Group of Statistics Canada provides overall management of the PHI to ensure that all activities and products are consistent with the objectives of the research program. HAMG team leaders and analysts assume responsibility for most of the methodologic aspects of the PHI, in particular, microsimulation modeling. The Policy Research Division of the Public Health Agency of Canada ensures the policy relevance of the PHI and encourages communication both within the Public Health Agency of Canada and with the Policy Advisory Committee. PRU team leaders and policy analysts contribute data management and subject matter support. Research collaboratorsThe PHI appreciates the collaboration of the following researchers: Les Roos, University of Manitoba Robert Spasoff, formerly of University of Ottawa Denis Roy, Agence de développement de réseaux locaux de services de santé et de services sociaux de la Montérégie Doug Manuel, Institute for Clinical Evaluative Sciences (ICES) Advisory committeesThree groups are consulted to ensure the policy relevance and appropriateness of the methodology used for this research program. Scientific Advisory CommitteeThe Scientific Advisory Committee reviews all aspects of the PHI, including study design and data analysis.
Policy Advisory CommitteeThe Policy Advisory Committee consists of individuals identified by the Advisory Committee on Population Health of the Conference of Deputy Ministers of Health and by the Strategic Policy Directorate of Health Canada. The Policy Advisory Committee reviews methodologic issues; provides guidance on the policy relevance of the program; and promotes the effective dissemination of the results.
Medical Review PanelThe Medical Review Panel, chaired by Denis Roy and Robert Spasoff, reviews and provides guidance on disease definitions. The members of the medical panel are Doug Manuel, Marie-Dominique Beaulieu, Charles Pless, and Alan Forster.
|
![]() |
|||
![]() |
Last Updated: 2006-11-01 | ![]() |